References
- Bhatt, J., Singh, S. G., Subbaiah, G., & Shah, B. (2007). A rapid and sensitive liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for the estimation of amlodipine in human plasma. Biomedical Chromatography, 21, 169–175.10.1002/(ISSN)1099-0801
- Chung, M., GlueA, Bramson P., & Clin, C. J. (2006). Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet. Pharmacology, 46, 1030–1037.
- Danafar, H., & Hamidi, M. (2013). A rapid and sensitive LC–MS method for determination of ezetimibe concentration in human plasma: Application to a bioequivalence study. Chromatographia, 76, 1667–1675.10.1007/s10337-013-2548-x
- Dollery, C. (1999). Therapeutic drugs (2nd ed., pp. 151–160). London: Churchill Livingstone.
- Goodman, A. G., Gilman, L. S, Rall, T. W., Nies, A. S., & Taylor, P. (1990). The pharmacological basis of therapeutics (8th ed., pp. 774–780). Oxford: Pergamon Press.
- Jacobsen, W., Kuhn, B.Soldner, A., Kirchner, G., Sewing, K. F., Kollman, P. A., … Chritians, U. (2000). It is important in the metabolism of many drugs including paclitaxel, rosiglitazone, mass spectrometer SCIEX API. Drug Metabolism and Disposition, 28, 1369–1378.
- Mcevoy, G. K. (2001). Determination of amlodipine besylate by charge-transfer complex formation with p-chloranilic acid (American Hospital Formulary Service®, pp. 488–865). Bethesda: American Society of Health-System Pharmacists.
- McKeage, K., & Siddiqui, M. A. (2008). Amlodipine/atorvastatin fixed-dose combination. American Journal of Cardiovascular Drugs, 8, 51–67.10.2165/00129784-200808010-00007
- Mohammadi, A., Rezanour, N., & Ansari, M. (2007). A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. Journal of Chromatography B, 846, 215–221.10.1016/j.jchromb.2006.09.007
- Molden, E., Skovlund, E., & Braathen, P. (2008). Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors. Drug Safety, 31, 587–596.
- Neil, M. J. O., Smith, A., Heckelman, P. E., & Budavari, S. (2001). The Merck index, an encyclopedia of chemicals, drugs and biologicals (13th ed., pp. 488–865). White House Station, NJ: Merck.
- Nirogi, R., Mudigonda, K., & Kandikere, V. (2007). Chromatography–mass spectrometry methods for the quantitation of statins in biological samples. Journal of Pharmaceutical and Biomedical Analysis, 44, 379–387.10.1016/j.jpba.2007.02.008
- Nováková, L., Vlčková, H., Šatínský, D., Sadílek, P., Solichová, D., Bláha, M., & Bláha, V. (2009). Ultra high performance liquid chromatography tandem mass spectrometric detection in clinical analysis of simvastatin and atorvastatin. Journal of Chromatography B, 877, 2093–2103.10.1016/j.jchromb.2009.05.052
- Pilli, N. R., Inamadugu, J. K., Mullangi, R., Karra, V. K., Vaidya, J. R., & Seshagiri Rao, J. V. L. N. (2011). Simultaneous determination of atorvastatin, amlodipine, ramipril and benazepril in human plasma by LC–MS/MS and its application to a human pharmacokinetic study. Biomedical Chromatography, 25, 439–449.10.1002/bmc.v25.4
- Ramani, A. V., Sengupta, P., & Mullangi, R. (2009). Development and validation of a highly sensitive and robust LC-ESI-MS/MS method for simultaneous quantitation of simvastatin acid, amlodipine and valsartan in human plasma: Application to a clinical pharmacokinetic study. Biomedical Chromatography, 23, 615–622.10.1002/bmc.v23:6
- Sweetman, S. C., & Martindale, D. (2005). The complete drug reference (34th ed., pp. 862–866). London: Pharmaceutical Press.
- Zhe, H. U., Fan-Yuan, Z., & Jin, Z. (2011). HPLC–MS–MS for the simultaneous determination of atorvastatin and amlodipine in plasma of hypertensive patients. Chromatographia, 73, 257–262.
- Zou, Q., Zhan, Y., Ge, Z., Wei, P., & Ouyang, P. (2009). Sensitive HPLC method with fluorescence detection and on-line wavelength switching for simultaneous determination of valsartan and amlodipine in human plasma. Arzneimittelforschung, 59, 383–391.